ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,055,000 | +6416.2% | 260,196 | +1697.6% | 0.09% | +8700.0% |
| Q4 2017 | $185,000 | -92.3% | 14,475 | -95.0% | 0.00% | -93.8% |
| Q2 2017 | $2,406,000 | +11.2% | 287,449 | +18.8% | 0.02% | -5.9% |
| Q1 2017 | $2,164,000 | +525.4% | 242,012 | +372.5% | 0.02% | +750.0% |
| Q3 2016 | $346,000 | +686.4% | 51,220 | +389.0% | 0.00% | – |
| Q4 2015 | $44,000 | -82.5% | 10,475 | -79.0% | 0.00% | -100.0% |
| Q4 2013 | $251,000 | -45.0% | 50,000 | -50.2% | 0.00% | -60.0% |
| Q2 2013 | $456,000 | – | 100,387 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |